General Information of DTT (ID: TT0CZBQ)

DTT Name Menin-MLL1 interaction (MEN1-KMT2A PPI) DTT Info
Gene Name MEN1-KMT2A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
KO-539 DM0NZYC Acute myeloid leukaemia 2A60 Phase 1/2 [1]
SNDX-5613 DMCGX9Y T lymphoblastic leukaemia 2B33.4 Phase 1/2 [2]
JNJ-75276617 DMR5RHG Haematological malignancy 2B33.Y Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Kura Oncology.
2 Clinical pipeline report, company report or official report of Syndax Pharmaceuticals.
3 Targeting the undruggable: menin inhibitors ante portas. J Cancer Res Clin Oncol. 2023 Sep;149(11):9451-9459.